SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival

Detalles Bibliográficos
Autores principales: Nuijten, M, Mickisch, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813753/
https://www.ncbi.nlm.nih.gov/pubmed/20051962
http://dx.doi.org/10.1038/sj.bjc.6605446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813753/
https://www.ncbi.nlm.nih.gov/pubmed/20051962
http://dx.doi.org/10.1038/sj.bjc.6605446

Ejemplares similares